Diabetes Care. 2013;36(10):3169-3176. During the baseline SHC, mean GFR was similar in type 2 diabetic (127 ± 34 mL/min) and healthy (128 ± 36 mL/min) subjects. During the repeat SHC after 7 days of ...
Objective—To examine the effect of dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, on the major components of renal glucose reabsorption (decreased maximum renal glucose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback